![]() |
| |
| | #1 (permalink) |
| Rank: New Member Join Date: Oct 2006
Posts: 7
| i am on day 11 and up 7.5lbs so far. was just posting this on a few other forums to get some feedback. hoping to get some replies on this one. thanx in advance. Pre-cycle – Run support supps for 3 weeks prior to cycle. Pre-cycle for 4 weeks/Support Supplements thru cycle: Hawthorn 1100 mg/ed, RYR=1200mg/ed Co-Q10=100mg/ed, Milk Thistle 1000mg/ed, Fish Oil 10-14 g/ed, ALA 600mg/ed Cycle Week 1 PP 10mg/day spaced within 24hrs. ex. 2:30am and 2:30am taken with breakfast and some EFA's at same times everyday Week 2-4 PP 20mg/day taken 8hrs apart, ex 2:30am and 10:30am-11pm, taking 2nd pill 1.5-2 hours before working out with meal, workout at 12pm. Additional “ON” supps Uni-Liver tabs- 6/day Animal Pak multi Post Cycle Therapy 5: 2ml tamoxifen citrate/ed-- RXT (25mg) -- Fenugreek 1g –-WB+GB—LX (75mg)--DHEA 200mgs/3days, 50mg/4days 6: 1.5ml tamoxifen citrate/ed-- RXT (50mg) -- Fenugreek 2g – WB+GB—LX (50mg)--ActivaTe 1600mg 7: 1ml tamoxifen citrate/ed-- RXT (50mg) - Fenugreek 3g – WB+GB—LX(25mg)--ActivaTe 1600mg--6oxo 1cap/ed 8: 1ml tamoxifen citrate/ed--Fenugreek 4g-- RXT (50mg) – WB+GB--Lx (25mg)ActivaTe 1600mg--6oxo 1cap/ed 9: RXT(50mg)--ActivaTe 1600mg--6oxo 1cap/ed 10:RXT(50mg)--ActivaTe 1600mg--6oxo 1cap/ed 11:RXT(50mg)--ActivaTe 1600mg 12:RXT(25mg) Support Supps from Cycle through post cycle therapy Week1-4 Cycle Support- 1 scoop with protein drink in morn and 1 scoop in eve w/ prot drink. Week 5BEGIN post cycle therapy- Cycle Support Week 6 - Cycle Support Week 7- Cycle Support Week 8 Finish remaining Cycle Support |
| |
| | #7 (permalink) | |
| Rank: Light Heavyweight Experience: 5-7 Years Join Date: Mar 2005
Posts: 3,512
| Quote:
Be very careful with the fenugreek, it effects your blood sugar and can cause crashes very easily especially at 4g. make sure your getting enough carbs around it. Why run RXT and 60x0, no real reason to do that, they are both AI's and will do the same thing. Taper the activate, and your looking good. | |
| | ||
| |
|
|